Efficacy and safety of enoxaparinversus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment

This publication has 18 references indexed in Scilit:

• A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery
  The American Journal of Surgery, 1995
• Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patients
  British Journal of Surgery, 1995
• Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery
  Annals of Internal Medicine, 1995
• Efficacy and Safety of Enoxaparin to Prevent Deep Venous Thrombosis after Hip Replacement Surgery
  Annals of Internal Medicine, 1994
• Deep venous thrombosis and occult malignancy: an epidemiological study
  BMJ, 1994
• Prophylaxis of postoperative thromboembolism with low molecular weight heparins
  British Journal of Surgery, 1993
• Low molecular weight heparin in prevention of perioperative thrombosis.
  BMJ, 1992
• Coagulation Abnormalities in Malignancy: A Review
  Seminars in Thrombosis and Hemostasis, 1992
• Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
  The Lancet, 1992
• A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery
  New England Journal of Medicine, 1986